HIIFS
ICPT

Harel Insurance Investments & Financial Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20
Closed -$3K – 458
2016
Q3 		$3K Sell
20
-40
-67% -$6.31K ﹤0.01% 442
2016
Q2 		$9K Sell
60
-40
-40% -$5.83K ﹤0.01% 570
2016
Q1 		$13K Sell
100
-36
-26% -$4.25K ﹤0.01% 334
2015
Q4 		$20K Buy
+136
New +$23K ﹤0.01% 253

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Harel Insurance Investments & Financial Services's ICPT Position: Q4 2016 in Review

Harel Insurance Investments & Financial Services sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2016, closing a stake of 20 shares — an estimated $3K sold.

Harel Insurance Investments & Financial Services first reported a position in ICPT in Q4 2015 and held it in 4 quarters. The position peaked at $20K in Q4 2015. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • Harel Insurance Investments & Financial Services reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 20 Intercept Pharmaceuticals, Inc. shares in Q4 2016, an estimated $3K.
  • Harel Insurance Investments & Financial Services first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2015 and held it in 4 quarters.
  • Harel Insurance Investments & Financial Services's Intercept Pharmaceuticals, Inc. position peaked at $20K in Q4 2015.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2016, filed 6 Feb 2017.